InMed Pharmaceuticals Inc.·4

Feb 28, 2:20 PM ET

WOUDENBERG MICHAEL 4

4 · InMed Pharmaceuticals Inc. · Filed Feb 28, 2022

Insider Transaction Report

Form 4
Period: 2022-02-23
WOUDENBERG MICHAEL
VP, Chem/Manufacturing/Control
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-02-23+5,00096,060 total
    Exercise: $1.01Exp: 2027-02-22Common shares (5,000 underlying)
Footnotes (1)
  • [F1]The options were granted on 2/23/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.

Documents

1 file
  • 4
    ownership.xmlPrimary